Close Menu

Testing the System

Britain's National Health Service aims to "test whether an entire health-care system is ready" for the personalized selection of cancer treatments via broad genetic testing, Nature News reports. "In its first phase, the program will be rolled out to as many as 12,000 NHS cancer patients over two years, beginning in early 2011," according to Nature.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.